Skip to main content
Erschienen in: Rheumatology International 6/2005

01.09.2005 | Original Article

Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis

verfasst von: Stefan Drinda, Sybille Franke, Michael Rüster, Peter Petrow, Oliver Pullig, Günter Stein, Gert Hein

Erschienen in: Rheumatology International | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Generation of advanced glycation end products (AGE) is an inevitable process in vivo and can be accelerated under pathologic conditions such as oxidative stress, e.g. in rheumatoid arthritis (RA). This process is mediated by the AGE-specific receptor (RAGE). In this study we analysed the presence of RAGE in RA and osteoarthritic (OA) synovial tissue using immunohistology.

Methods

Frozen synovial tissue samples from 11 RA patients and 12 OA patients were treated with goat anti-RAGE immunoglobulin G (IgG) and rabbit antigoat IgG. Immunostaining was visualised with streptavidin horse radish peroxidase (chromogen amino-ethyl-carbazole). Cell differentiation was performed with antibodies against CD68, CD45RO, and CD20.

Results

In 9/11 RA and 8/12 OA synovial specimens, RAGE was detected in synovial lining, sublining, and stroma. In RA, many T cells (CD45RO+) and some macrophages (CD68+) showed positive immunostaining for RAGE, whereas B cells were mostly negative. We found no difference in staining patterns between the RA and OA samples.

Conclusions

We detected RAGE in RA and OA synovial tissue. The presence of RAGE on macrophages, T cells, and some B cells suggests its role in the pathogenesis of inflammatory joint disease.
Literatur
1.
Zurück zum Zitat Miyata T, Ishiguro N, Yasuda Y (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and in relation with inflammatory markers. Biochem Biophys Res Commun 244:49CrossRef Miyata T, Ishiguro N, Yasuda Y (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and in relation with inflammatory markers. Biochem Biophys Res Commun 244:49CrossRef
2.
Zurück zum Zitat Takahashi M, Kushida K, Ohishi T (1994) Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum 37:724–728PubMed Takahashi M, Kushida K, Ohishi T (1994) Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum 37:724–728PubMed
3.
Zurück zum Zitat Chen JR, Takahashi M, Suzuki M, Kushida S, Miyamoto S, Inoue T (1999) Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Br J Rheum 38:1275–1278CrossRef Chen JR, Takahashi M, Suzuki M, Kushida S, Miyamoto S, Inoue T (1999) Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Br J Rheum 38:1275–1278CrossRef
4.
Zurück zum Zitat Drinda S, Franke S, Canet CC, Petrow P, Brauer R, Huttich C et al (2002) Identification of the advanced glycation end product N (epsilon) carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Ann Rheum Dis 61:488–492CrossRefPubMed Drinda S, Franke S, Canet CC, Petrow P, Brauer R, Huttich C et al (2002) Identification of the advanced glycation end product N (epsilon) carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Ann Rheum Dis 61:488–492CrossRefPubMed
5.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed
6.
Zurück zum Zitat Vlassara H (1996) Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49:1795–1804PubMed Vlassara H (1996) Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49:1795–1804PubMed
7.
Zurück zum Zitat Vlassara H (1996) Advanced glycation end-products and atherosclerosis. Ann Med 28:419–426PubMed Vlassara H (1996) Advanced glycation end-products and atherosclerosis. Ann Med 28:419–426PubMed
8.
Zurück zum Zitat Colaco C, Ledesma MD, Harrington CR, Avila J (1996) The role of the Maillard reaction in other pathologies: Alzheimer’s disease. Nephrol Dial Transplant 11:7–12PubMed Colaco C, Ledesma MD, Harrington CR, Avila J (1996) The role of the Maillard reaction in other pathologies: Alzheimer’s disease. Nephrol Dial Transplant 11:7–12PubMed
9.
Zurück zum Zitat Miyata M, Iida Y, Horie K, Cai Z, Sugiyama S, Maeda K (1996) Pathophysiology of advanced glycation end-products in renal failure. Nephrol Dial Transplant 1:27–80 Miyata M, Iida Y, Horie K, Cai Z, Sugiyama S, Maeda K (1996) Pathophysiology of advanced glycation end-products in renal failure. Nephrol Dial Transplant 1:27–80
10.
Zurück zum Zitat Friedlander MA, Wu YC, Elgawish A, Monnier VM (1996) Early and advanced glycosylation end products—kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97:728–735 Friedlander MA, Wu YC, Elgawish A, Monnier VM (1996) Early and advanced glycosylation end products—kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97:728–735
11.
Zurück zum Zitat McCarthy AD, Etcheverry SB, Bruzzone L, Cortizo AM (1997) Effects of advanced glycation end products on the proliferation and differentiation of osteoblast-like cells. Mol Cell Biochem 170:43–51CrossRefPubMed McCarthy AD, Etcheverry SB, Bruzzone L, Cortizo AM (1997) Effects of advanced glycation end products on the proliferation and differentiation of osteoblast-like cells. Mol Cell Biochem 170:43–51CrossRefPubMed
12.
Zurück zum Zitat Miyata T, Kawai R, Taketomi S, Sprague SM (1996) Possible involvement of advanced glycation end products in bone resorption. Nephrol Dial Transplant 11:54–57 Miyata T, Kawai R, Taketomi S, Sprague SM (1996) Possible involvement of advanced glycation end products in bone resorption. Nephrol Dial Transplant 11:54–57
13.
Zurück zum Zitat Takagi M, Kasayama S, Yamamoto T (1997) Advanced glycation end products stimulate interleukin 6 production by human bone derived cells. J Bone Miner Res 12:439–446PubMed Takagi M, Kasayama S, Yamamoto T (1997) Advanced glycation end products stimulate interleukin 6 production by human bone derived cells. J Bone Miner Res 12:439–446PubMed
14.
Zurück zum Zitat Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S et al (1999) N-carboxymethyllysine adducts of proteins are ligands for receptors for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 44:31740–31749CrossRef Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S et al (1999) N-carboxymethyllysine adducts of proteins are ligands for receptors for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 44:31740–31749CrossRef
15.
Zurück zum Zitat Thornalley P (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44:1013–1023 Thornalley P (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44:1013–1023
16.
Zurück zum Zitat Takahashi M, Suzuki M, Kushida K (1997) Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br J Rheum 36:637–642CrossRef Takahashi M, Suzuki M, Kushida K (1997) Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br J Rheum 36:637–642CrossRef
17.
Zurück zum Zitat Stern DM, Yan SD, Yan SF, Schidt AM (2002) Receptor for advanced glycation endproducts (RAGE) and complications of diabetes. Ageing Res Rev 1:1–15CrossRefPubMed Stern DM, Yan SD, Yan SF, Schidt AM (2002) Receptor for advanced glycation endproducts (RAGE) and complications of diabetes. Ageing Res Rev 1:1–15CrossRefPubMed
Metadaten
Titel
Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis
verfasst von
Stefan Drinda
Sybille Franke
Michael Rüster
Peter Petrow
Oliver Pullig
Günter Stein
Gert Hein
Publikationsdatum
01.09.2005
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2005
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0456-y

Weitere Artikel der Ausgabe 6/2005

Rheumatology International 6/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.